The share price of Central Garden & Pet Company (CENT) has plummeted nearly 33% over the past quarter in response to disappointing sales and earnings performance during the first quarter of FY19.
This significant decline in share price is also attributable to a weak outlook as the company is projecting its earnings per share to drop by 22% during FY19 due to mounting costs pressure and a notable increase in the number of shares. I think, a lot of negatively is already priced in, and it appears to be a good time to buy the stock for a decent upside as the initiatives like increase in selling prices and rollout of new products coupled with the favorable demand dynamics will positively impact the stock price.
The poor performance of pet animal health business is attributable to the entry of a more aggressive competitor.
The latest articles
US: majority of pet owners still underestimate pet obesity
Obesity rates among cats and dogs in America have risen in the past 15 years, with the increase particularly pronounced in cats.
Pet Care
10 Oct 2024
French fermentation player acquires majority stake in Biorigin
Lesaffre, a global yeast manufacturer based in France, will become the controlling shareholder of the Brazilian company.
Global Pet Industry
10 Oct 2024
New proposals seek to expand tax benefits for vet care in the US
Two bills aim to expand vet care tax relief benefits and strengthen protections for dogs used for breeding.
Pet Care
9 Oct 2024
GET THE NEWSLETTER
Weekly newsletter to stay up-to-date
Discover what’s happening in the pet industry. Get the must-read stories and insights in your inbox.